| 000 | 01819 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515055338.0 | ||
| 264 | 0 | _c20070522 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/j.pbb.2006.12.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodgson, R A | |
| 245 | 0 | 0 |
_aComparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cMar 2007 |
||
| 300 |
_a431-40 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntidiuretic Hormone Receptor Antagonists |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aConditioning, Psychological _xdrug effects |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Vasopressin _xmetabolism |
| 650 | 0 | 4 |
_aVocalization, Animal _xdrug effects |
| 650 | 0 | 4 | _aCRF Receptor, Type 1 |
| 700 | 1 | _aHiggins, G A | |
| 700 | 1 | _aGuthrie, D H | |
| 700 | 1 | _aLu, S X | |
| 700 | 1 | _aPond, A J | |
| 700 | 1 | _aMullins, D E | |
| 700 | 1 | _aGuzzi, M F | |
| 700 | 1 | _aParker, E M | |
| 700 | 1 | _aVarty, G B | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 86 _gno. 3 _gp. 431-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pbb.2006.12.021 _zAvailable from publisher's website |
| 999 |
_c16851619 _d16851619 |
||